Stimulus Responsive Nanocarrier for Enhanced Antitumor Responses Against Hepatocellular Carcinoma
These encouraging results highlight the potential of our nanocarrier system as an innovative therapeutic approach to address HCC primary tumor and postsurgical recurrence, providing hope for enhanced patient outcomes.
Authors
- Deteng Zhang (ORCID: https://orcid.org/0000-0001-9526-9122)
- Zhenghui Jing
- Huan Qin (ORCID: https://orcid.org/0000-0002-2398-8758)
- Jinxiao Song
- Jingyi Zhou (ORCID: https://orcid.org/0000-0003-4229-7888)
- Xinlong Zang (ORCID: https://orcid.org/0000-0002-9250-2782)
- You Wu (ORCID: https://orcid.org/0000-0002-0896-4475)
Institutions
- Qingdao University (CN)
- Affiliated Hospital of Qingdao University (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/ijn.s486465
- Citations
- 54
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 9.36